GM Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.58M | Buy |
3,208
+351
| +12% | +$190K | 0.06% | 127 |
|
|
2025
Q4 | $1.66M | Sell |
2,857
-17
| -0.6% | -$9.61K | 0.06% | 123 |
|
|
2025
Q3 | $1.39M | Buy |
2,874
+2
| +0.1% | +$931 | 0.06% | 126 |
|
|
2025
Q2 | $1.16M | Buy |
2,872
+704
| +32% | +$294K | 0.06% | 134 |
|
|
2025
Q1 | $1.08M | Buy |
2,168
+15
| +0.7% | +$8.12K | 0.06% | 126 |
|
|
2024
Q4 | $1.12M | Sell |
2,153
-166
| -7% | -$91.3K | 0.06% | 114 |
|
|
2024
Q3 | $1.43M | Buy |
2,319
+370
| +19% | +$219K | 0.09% | 92 |
|
|
2024
Q2 | $1.08M | Buy |
1,949
+38
| +2% | +$21.8K | 0.07% | 110 |
|
|
2024
Q1 | $1.11M | Buy |
1,911
+10
| +0.5% | +$5.61K | 0.08% | 104 |
|
|
2023
Q4 | $1.01M | Buy |
1,901
+1
| +0.1% | +$484 | 0.08% | 95 |
|
|
2023
Q3 | $962K | Buy |
1,900
+1
| +0.1% | +$533 | 0.08% | 84 |
|
|
2023
Q2 | $991K | Hold |
1,899
| – | – | 0.08% | 84 |
|
|
2023
Q1 | $1.09M | Hold |
1,899
| – | – | 0.1% | 68 |
|
|
2022
Q4 | $1.05M | Hold |
1,899
| – | – | 0.11% | 69 |
|
|
2022
Q3 | $963K | Buy |
1,899
+133
| +8% | +$74.4K | 0.12% | 66 |
|
|
2022
Q2 | $959K | Sell |
1,766
-115
| -6% | -$63.3K | 0.15% | 69 |
|
|
2022
Q1 | $1.11M | Sell |
1,881
-575
| -23% | -$330K | 0.13% | 84 |
|
|
2021
Q4 | $1.64M | Buy |
2,456
+146
| +6% | +$91.2K | 0.15% | 76 |
|
|
2021
Q3 | $1.32M | Buy |
2,310
+40
| +2% | +$22K | 0.13% | 77 |
|
|
2021
Q2 | $1.15M | Hold |
2,270
| – | – | 0.12% | 86 |
|
|
2021
Q1 | $1.04M | Hold |
2,270
| – | – | 0.12% | 81 |
|
|
2020
Q4 | $1.06M | Hold |
2,270
| – | – | 0.14% | 68 |
|
|
2020
Q3 | $1M | Hold |
2,270
| – | – | 0.15% | 63 |
|
|
2020
Q2 | $823K | Hold |
2,270
| – | – | 0.15% | 67 |
|
|
2020
Q1 | $644K | Hold |
2,270
| – | – | 0.18% | 64 |
|
|
2019
Q4 | $737K | Sell |
2,270
-226
| -9% | -$68.5K | 0.23% | 39 |
|
|
2019
Q3 | $727K | Hold |
2,496
| – | – | 0.23% | 46 |
|
|
2019
Q2 | $733K | Hold |
2,496
| – | – | 0.23% | 51 |
|
|
2019
Q1 | $683K | Hold |
2,496
| – | – | 0.22% | 51 |
|
|
2018
Q4 | $559K | Hold |
2,496
| – | – | 0.21% | 56 |
|
|
2018
Q3 | $609K | Hold |
2,496
| – | – | 0.19% | 61 |
|
|
2018
Q2 | $517K | Hold |
2,496
| – | – | 0.15% | 65 |
|
|
2018
Q1 | $515K | Hold |
2,496
| – | – | 0.16% | 61 |
|
|
2017
Q4 | $474K | Buy |
2,496
+1,200
| +93% | +$230K | 0.13% | 67 |
|
|
2017
Q3 | $245K | Sell |
1,296
-12
| -0.9% | -$2.17K | 0.07% | 99 |
|
|
2017
Q2 | $228K | Buy |
+1,308
| New | +$220K | 0.07% | 99 |
|
Other funds holding TMO
VCM
GM Advisory Group's TMO Position: Q1 2026 in Review
GM Advisory Group increased its Thermo Fisher Scientific (TMO) stake by 12% in Q1 2026, buying an estimated $190K and bringing the position to 3,208 shares worth $1.58M. The position accounts for 0.06% of the portfolio, ranked #127.
GM Advisory Group first reported a position in TMO in Q2 2017 and has held it in 36 quarters since. The position peaked at $1.66M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- GM Advisory Group held 3,208 shares of Thermo Fisher Scientific worth $1.58M as of Q1 2026.
- GM Advisory Group bought 351 Thermo Fisher Scientific shares in Q1 2026, an estimated $190K.
- Thermo Fisher Scientific made up 0.06% of GM Advisory Group's portfolio in Q1 2026, its #127 holding.
- GM Advisory Group first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 36 quarters since.
- GM Advisory Group's Thermo Fisher Scientific position peaked at $1.66M in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.